Europe Pharmaceutical Packaging Market

The report "Europe Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Forecast to 2030", is projected to reach USD 95.78 billion by 2030 from USD 49.24 billion in 2025, at a CAGR of 14.2% during the forecast period.

Browse 173 market data Tables and 73 Figures spread through 230 Pages and in-depth TOC on "Europe Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-pharmaceutical-packaging-market-34761714.html

The Europe pharmaceutical packaging market across primary and secondary applications has experienced substantial growth, primarily because safety, efficacy, and compliance requirements are becoming increasingly stringent across oral, injectable, and topical drug delivery formats. The growing global demand for patient-friendly, tamper-evident, and sustainable packaging means we have to develop new packaging options that protect integrity, stability, and dosages while also maintaining compliance with regulatory expectations, and the trends are shifting toward new drug formulations and personalized medicine. Commonly used products such as plastic bottles, blister packs, prefillable syringes, vials, and tubes are designed to deliver some of the most critical and sought-after performance attributes, including barrier protection, sterility, ease of use, and extended shelf life in challenging storage and transportation conditions. A key market driver is the emphasis on recyclable and sustainable packaging systems backed by regulatory authorities and the pharmaceutical sector’s focus on achieving carbon-neutral and circular economy initiatives. Furthermore, advancements in smart packaging technologies, including RFID-enabled tracking, digital dose reminders, and connected care devices, offer patient adherence, supply chain transparency, and reduced medicine waste. This illustrates that pharmaceutical packaging is extending beyond compliance and protection to consider innovation, safety of patients, and sustainability in health care markets.

Plastic bottles are set to form the largest segment by type during the forecast period

Plastic bottles will be the largest segment by type during the forecast period. Plastic bottles are expected to remain the largest segment in the Europe pharmaceutical packaging market in terms of value during the forecast period. Their dominance is supported by wide applications in packaging tablets, capsules, oral liquids, and OTC medicines. Plastic bottles offer many benefits, including their low weight, durability, cost-effectiveness, and design versatility. The increasing incorporation of child-resistant and tamper-evident closures offers increased patient safety and regulatory compliance, driving plastic bottle demand. New formulations of resin and barrier technologies are improving moisture and oxygen resistance with plastic bottles, allowing them to be used in more sensitive pharmaceutical formulations as well. With the development of sustainable and recyclable plastics, plastic bottles remain the primary choice in Europe.

Primary packaging is estimated to be the largest segment by packaging type during the forecast period

In the European pharmaceutical packaging sector, primary packaging commands the largest share. Primary packaging primarily protects drug formulations from various threats while maintaining sterility, stability, and the drug product’s suitability for patient use. This section mainly comprises formats such as vials, blister packs, ampoules, and prefillable syringes. The growth in biologics, vaccines, and injectable therapies is also increasing the demand for new sterile primary packaging formats on the market. For example, regulations to protect patients from harm and to track and report changes to drug products, implementing design features to provide added protection against counterfeiting, and extending the shelf life of drug products will help support the primary packaging segment of the pharmaceutical packaging market. As part of this, advances in smart primary packaging and technology, such as digital smart blister packs for monitoring adherence and RFID-enabled vials, demonstrate that innovation is extending the function of primary packaging beyond containment and better informing the market that smart primary packaging is on the rise.

Injectables are projected to be the most in-demand drug delivery system in Europe during the forecast period

The injectables market is also expected to be the leading market for pharmaceutical packaging of various drugs by delivery system in the forecast period. The injectables market, in terms of value, has remained dominated by a substantial and growing demand for pharmaceutical packaging, driven by the rising use of biologics, vaccines, biosimilars, and specialty drugs in the region. The demand for these drugs has resulted in the need for appropriate and advanced primary packaging products such as vials, prefilled syringes, cartridges, and ampoules, which need to comply with the stringent requirements of the European market, such as sterility, barrier resistance, and chemical resistance. The trend toward the use of ready-to-use and prefilled delivery systems has also helped ensure accurate dose delivery, infection safety, and ease of use.

Germany is projected to be the largest market by country during the forecast period

Germany is expected to be the leading market in the Europe pharmaceutical packaging market. It is expected to be the most significant contributor to the pharmaceutical packaging demand in Europe. This is because Germany has strong pharmaceutical manufacturing capacity and a highly developed healthcare infrastructure. Germany leads in pharmaceutical production and biologics production. Germany has an aged population and is characterized by chronic and specialty diseases. Germany is characterized by high spending on healthcare. This is expected to positively impact the pharmaceutical packaging demand. Germany is an important hub for pharmaceutical exports to other regions of Europe. This is expected to increase the demand for pharmaceutical vials, syringes, blisters, and other compliant packaging.

German pharmaceutical packaging manufacturers are subject to some of the most stringent regulations and quality norms in Europe, as they are compliant with EU GMP, European Medicines Agency (EMA), and EU Falsified Medicines Directive (FMD). These requirements are encouraging continued investment in advanced materials, cleanroom manufacturing, and digitalized packaging technologies. The report profiles key companies, including Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Nolato AB (Sweden), and Smurfit Westrock (Ireland), which are some major players in the Europe pharmaceutical packaging market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.

Don’t miss out on business opportunities in Europe Pharmaceutical Packaging Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/